Open access
Aug 2026
A CEBPB-IPO4-FASN-MAVS axis limits innate immune activation and viral pneumonia.
Results indicate that the CEBPB-IPO4-FASN-MAVS axis preserves innate immune homeostasis to avoid inflammatory pathology, highlighting IPO4 as a potential therapeutic target for severe viral pneumonia.
Jing Wu, Zi-Hang Chen, Shengxiang Yin et al.
· Cell Reports · 0 citations